Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Activities of clinafloxacin, gatifloxacin, gemifloxacin, and trovafloxacin against recent clinical isolates of levofloxacin-resistant Streptococcus pneumoniae.
Horizontal transfer of fluoroquinolone resistance genes in Streptococcus pneumoniae
Mutations in parE are associated with fluoroquinolone resistance.
Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
Mutation in parE leads to quinolone resistance
Comparative study of the mutant prevention concentrations of moxifloxacin, levofloxacin, and gemifloxacin against pneumococci.
mutations in quinolone resistance-determining region associated with resistance to fluoroquinolones
Rapid pneumococcal evolution in response to clinical interventions.
Characterization of recombinant fluoroquinolone-resistant pneumococcus-like isolates.
Mutations in parE gene associated with fluoroquinolone resistance.
Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae.
Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones.
Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae.
Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa.
Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001.
Mutations in parE contribute to fluoroquinolone resistance.
Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US Study.
Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.
Molecular characterization of fluoroquinolone resistance in invasive clinical isolates of Streptococcus pneumoniae susceptible to delafloxacin.
Mutations in parE are associated with fluoroquinolone resistance
Genetic diversity of fluoroquinolone-nonsusceptible Streptococcus pneumoniae clinical isolates and the first identification of serotype 20B in China.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research